Medicus Sciences Acquisition Corp. (the “Company”) (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Charter”), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.18.
Apple’s Groundbreaking iPhone 16 Could Spark Another Stock Surge Building On An 800% Growth Over The Last Decade
Apple plans to introduce the iPhone 16 at their September event, promising to redefine mobile technology.
The iPhone 16 Pro Max will feature an improved battery with higher energy density, offering longer battery life.
